Eli Lilly traded at $322.71 this Tuesday July 5th, decreasing $2.00 or 0.62 percent since the previous trading session. Looking back, over the last four weeks, Eli Lilly lost 6.38 percent. Over the last 12 months, its price rose by 37.08 percent. Looking ahead, we forecast Eli Lilly to be priced at 315.91 by the end of this quarter and at 290.92 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
322.71
Daily Change
-0.62%
Yearly
37.08%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 152.69 -1.11 -0.72% 31.94%
Abbott 108.56 -1.66 -1.51% -8.63%
ALKERMES 30.51 -0.02 -0.07% 19.37%
Amgen 244.27 -1.28 -0.52% 0.25%
AstraZeneca 10,800.00 -8.00 -0.07% 23.84%
Astrazeneca 64.70 -1.25 -1.90% 8.01%
Baxter International 64.57 -0.92 -1.40% -20.35%
Biogen 210.83 0.20 0.09% -38.87%
Bristol-Myers Squibb 75.25 -1.58 -2.06% 12.90%
Coherus Biosciences 8.24 0.41 5.24% -39.55%
Catalent 104.44 -2.58 -2.41% -7.70%
Endo International 0.55 -0.02 -4.01% -87.59%
Gilead Sciences 61.84 -0.52 -0.83% -9.60%
GlaxoSmithKline 1,786.60 -16.00 -0.89% 24.57%
Glaxosmithkline 42.83 -0.93 -2.11% 6.90%
Horizon Pharma 82.37 1.53 1.89% -14.00%
Intercept Pharmaceuticals 14.83 0.70 4.95% -22.11%
Jazz Pharmaceuticals 155.61 -2.98 -1.88% -14.94%
J&J 176.59 -2.93 -1.63% 5.13%
Lannett 0.59 0.03 4.78% -87.16%
Eli Lilly 322.71 -2.00 -0.62% 37.08%
Medtronic 89.96 -1.42 -1.55% -29.15%
Merck & Co 91.75 -0.67 -0.72% 17.46%
Neurocrine Biosciences 97.91 -1.34 -1.35% 0.47%
Novartis 80.91 -0.74 -0.91% -4.31%
Novartis 83.54 -0.82 -0.97% -8.78%
Phibro Animal Health 19.82 0.23 1.17% -31.13%
Prestige Brands 59.09 -0.49 -0.82% 14.10%
Pfizer 50.99 -1.32 -2.52% 29.78%
Perrigo 40.32 -0.70 -1.71% -14.03%
Drreddys Laboratories 55.26 -0.58 -1.04% -25.68%
Regeneron Pharmaceuticals 586.04 -9.36 -1.57% 0.65%
Roche Holding 319.00 -3.60 -1.12% -9.76%
Revance Therapeutics 14.45 0.12 0.84% -54.91%
Sanofi 97.12 -1.22 -1.24% 11.93%
Sanofi 49.88 -1.13 -2.22% -3.01%
Teva Pharmaceutical Industries 7.72 -0.17 -2.15% -19.67%
United Therapeutics 235.74 -2.26 -0.95% 27.24%
Zoetis 172.60 -1.61 -0.92% -11.04%

Indexes Price Day Year
US500 3795 -30.14 -0.79% -12.62%

Eli Lilly
Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its Oncology products include Alimta, Cyramza, Erbitux and Verzenio. Other product includes Cialis, for the tratment of erectile dysfunction and benign prostatic hyperplasia. The Company manufacture and distribute its products through facilities in the United States, Puerto Rico, and 8 other countries. Its products are sold in approximately 120 countries.